Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Rite Aid March Same-Store Sales Rose 3.6%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/05/2012 | 03:02pm CET

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.6% in March, continuing a streak of monthly growth for the drugstore chain.

The No. 3 U.S. drugstore chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month during 2011; March 2011 had a 0.1% drop. Last month Rite Aid reported its fourth-quarter same-store sales rose 3%, its best showing in five years.

Analysts have been expecting Rite Aid and CVS to gain market share as a result of Walgreen's exiting pharmacy benefits manager Express Scripts Holding Co.'s (ESRX) network late last year. The move was expected to result in some of Walgreen's customers going to competitors such as Rite Aid to fill prescriptions.

During March, same-store sales were up 4.6% in the front of the store.

Pharmacy same-store sales increased 3.2%, despite a negative impact of 2.4 percentage points from generic drug introductions. Same-store prescription counts grew 2.6%.

Total March drugstore sales rose 3.1% to $1.99 billion. Prescription sales accounted for 69.2% of drugstore sales.

Rite-Aid, which has about 4,659 stores, has posted losses since its 2007 acquisition of the Brooks and Eckerd chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed on higher same-store sales as the drugstore chain's wellness and loyalty and flu-immunization programs lifted pharmacy-department sales.

Shares were up 2.3% at $1.75 in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stocks mentioned in the article : Rite Aid Corporation, CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
01/13 RITE AID : scammer can't dodge date with prison cell, U.S. judge rules
01/12 RITE AID'S DAYS NUMBERED AS WALGREEN : reports
01/12 RITE AID : Foundation Welcomes New Year with New Class of KidCents Charities
01/11 RITE AID : Irvington Police Warn Local Business Owners Of Phone Scam Involving C..
01/11 RITE AID : Shopping center that houses Rite Aid's operational headquarters and D..
01/05 RITE AID : Management's Discussion and Analysis of Financial Condition and Resul..
01/05DJWALGREENS BOOTS CEO : No Plan B for Rite Aid Merger--Update
01/05 RITE AID CORPORATION : Post Earnings Coverage as Rite Aid Top- and Bottom-line B..
01/05DJWalgreens Boots Profit Slips--Update
01/05DJWalgreens Boots Raises Low End of Annual Guidance
More news
Sector news : Retail - Drugs without Grocery
03:03aDJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders --..
01:47aDJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders
01/11DJWalgreens to Offer FedEx Dropoff and Pickup at Walgreens Locations Nationwide
01/05 U.S. loses bid to overturn AmEx antitrust decision
01/05DJWALGREENS BOOTS CEO : No Plan B for Rite Aid Merger--Update
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
07:30a What To Do When Markets Are Fully Priced (Chris DeMuth)
01/16 A Better Way To Profit From The Walgreens Boots Alliance / Rite Aid Deal
01/12 MIRACLE FORMULA INVESTING : Performing An Investment Miracle With CVS Health Cor..
01/11 Amazon Offers 5% Off Of Everything
01/11 What To Make Of The Walgreens And FedEx Partnership
Advertisement
Financials ($)
Sales 2017 32 593 M
EBIT 2017 502 M
Net income 2017 69,1 M
Debt 2017 6 989 M
Yield 2017 -
P/E ratio 2017 144,50
P/E ratio 2018 123,86
Capi. / Sales 2017 0,49x
Capi. / Sales 2018 0,28x
Capitalization 9 124 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 8,88 $
Spread / Average Target 2,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION5.22%9 124
RAIA DROGASIL SA2.40%6 593
AIN HOLDINGS INC3.10%2 245
ORIOLA KD OYJ-1.16%825
AUSTRALIAN PHARMACEUTI..-0.97%754
ADCOCK INGRAM HOLDINGS..2.48%640
More Results